Sustainability Report

Overview

The report is Tanvex BioPharma's first sustainability report and covers its headquarters and subsidiaries in Taiwan and the United States for 2022. Highlights include establishing a Sustainable Development Committee, identifying 10 material topics, and adopting the TCFD framework. The company reports 1,057.24 tCO2e of Scope 1 emissions, 2,421.97 tCO2e of Scope 2 emissions, 40,551.06 gigajoules of energy consumption, 98.66 metric tons of waste, and 2,400 metric tons of water consumption. Social disclosures include 206 trained employees, 5,413 training hours, and 100% retention after parental leave.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2022
Period: 1 January 2022 – 31 December 2022
Language: English
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services